Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Fondaparinux (atc Code 2026-10-27
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Nadroparin (atc Code 2026-10-27
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin (atc Code B03xa01). 2026-10-27
United Kingdom Provision Of Medical Services To Nhs Scotland Health Boards 2026-10-29
United Kingdom Children And Young People Continuing Healthcare 2026-10-31
Germany Open House Original Rebate Agreements 202409 Nintedanib (finished Medicinal Product Name Ofev(r)) 2026-10-31
Germany Openhousebiologics Discount Contracts 202411 Hepatitis Immune Globulin (atccode J06bb04) 2026-10-31
Germany Medicinal Products Containing The Active Ingredient Levothyroxine Sodium (h03aa01) Within The Framework Of A So-called Open House Model. 2026-10-31
Germany  medicinal Products Containing The Active Ingredient Cetrorelix (h01cc02) Within The Framework Of A So-called Open House Model. 2026-10-31
Germany   Medicinal Products Containing The Active Ingredient Fluorouracil, Combinations (d11af55) Within The Framework Of A So-called Open House Model. 2026-10-31
Whats app